The clinical relevance of this correlation was also reinforced by a significant group × [18F]-AV1451 binding interaction, indicating that tau was more strongly related to poorer cognition in the DLB group relative to healthy controls or AD. The gene discussed is MAPT; the disease is Lewy body dementia.